The mTORC1 effectors S6K1 and 4E-BP play different roles in CNS axon regeneration.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25382660.
- Also identified by DOI 10.1038/ncomms6416 and PMC identifier 4228696.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Using mouse optic nerve (ON) crush as a CNS injury model, we and others have found that activation of the mammalian target of rapamycin complex 1 (mTORC1) in mature retinal ganglion cells by deletion of the negative regulators, phosphatase and tensin homologue (PTEN), and tuberous sclerosis 1 promotes ON regeneration. mTORC1 activation inhibits eukaryotic translation initiation factor 4E-binding protein (4E-BP) and activates ribosomal protein S6 kinase 1 (S6K1), both of which stimulate translation. We reasoned that mTORC1's regeneration-promoting effects might be separable from its deleterious effects by differential manipulation of its downstream effectors. Here we show that S6K1 activation, but not 4E-BP inhibition, is sufficient to promote axon regeneration. However, inhibition of 4E-BP is required for PTEN deletion-induced axon regeneration. Both activation and inhibition of S6K1 decrease the effect of PTEN deletion on axon regeneration, implicating a dual role of S6K1 in regulating axon growth.
Medical subject headings
- Axons
- Carrier Proteins
- Central Nervous System
- Multiprotein Complexes
- Nerve Regeneration
- Phosphoproteins
- Ribosomal Protein S6 Kinases, 90-kDa
- TOR Serine-Threonine Kinases